Search Results

Site Search

Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights

In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections.

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

CPT codes and LOINC update: October 2020 - Insights

The following list includes updates posted to mayocliniclabs.com during the month of October.

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

Renal - Insights

Mayo Clinic Laboratories’ nephrology experts, pathologists, and laboratory scientists uphold the highest standards of renal laboratory care.

University of Louisville: Building an evidence-based algorithm to guide autoimmune neurology patient care - Insights

UofL Health – UofL Hospital physicians and laboratory scientists faced challenges in the ordering of autoimmune and paraneoplastic panels: duplicate orders that add unnecessary cost and omitted test orders that could provide the key to the...

Week in Review: April 21 - Insights

Top highlights include: Millions expected to lose dental care coverage, overdose deaths of elderly on the rise, and Minnesota Health Department urges caution for well owners as flood waters rise.

Final Rule on LDTs May Be Coming Soon: Bill Morice, M.D., Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the...

Black History Month: Bill Morice, M.D., Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to honor Black...